Bo Lian

Air Force Medical University

Papers

1

Total Citations

56

H-Index

1

About

Bo Lian is a leading surgical oncologist whose research focuses on minimally invasive techniques for gastric cancer treatment, with a particular emphasis on comparing robotic and laparoscopic approaches. In his landmark 2018 study, "Robotic versus laparoscopic gastrectomy with D2 lymph node dissection for advanced gastric cancer," Lian addressed a critical gap in surgical oncology by evaluating the short- and long-term outcomes of robotic gastrectomy (RG) versus laparoscopic gastrectomy (LG) for advanced gastric cancer. Using propensity score-matched analysis, his work provided rigorous evidence on the safety and efficacy of RG as an alternative to LG, demonstrating comparable oncologic outcomes while highlighting potential advantages in surgical precision. This highly cited paper (56 citations) has significantly influenced clinical decision-making and surgical practice, helping to establish robotic surgery as a viable option for advanced gastric cancer. Lian’s contributions have advanced the field of gastric cancer surgery, offering patients and surgeons evidence-based insights into the benefits of robotic techniques, and his work continues to shape the evolution of minimally invasive oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Robotic versus laparoscopic gastrectomy with D2 lymph node dissection for advanced gastric cancer: a propensity score-matched analysis
56 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Air Force Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago